arXiv subjects

Karanjit Kooner

Publications and source records attributed to Karanjit Kooner.

5 recordsLinked to original sources

arXiv2026

GlaKG: A Biomarker-Centric Fundus Knowledge Graph for Explainable Glaucoma Diagnosis and Risk Assessment

Glaucoma is a leading cause of irreversible blindness worldwide, yet most automated diagnosis systems rely on opaque deep-learning models that offer little clinical interpretability. We present GlaKG, a biomarker-centric fundus knowledge graph that integrates structural biomarkers, clinically grounded rules, and image features to produce traceable reasoning for glaucoma diagnosis and risk stratification. GlaKG encodes six entity types (Fundus Image, Optic Disc, Neural Rim, Pathology, Diagnosis, Risk Level), eight relation types, and 11 clinically validated rules into a unified graph, so that every prediction is accompanied by an explicit reasoning chain linking biomarker evidence to activated clinical rules. To keep knowledge-based reasoning strictly separate from label information, we adopt a post-processing fusion framework that combines ResNet50 image embeddings with a normalized KG reasoning-chain score via a tunable weight alpha, with all fitting confined to the training split. On a publicly available, AI-annotated fundus dataset, GlaKG reaches F1 = 0.9953 for binary glaucoma classification and 0.930 accuracy with 0.922 weighted F1 for four-class risk stratification; we report openly that the dataset's biomarker annotations are highly label-correlated, and therefore frame these figures as an upper bound attainable with clean structured biomarkers rather than as leakage-free image-only performance. Feature-importance analysis shows KG-derived and biomarker features contributing near-equally (51.1% vs. 48.9%), and the reasoning chain flags borderline cases by exposing low chain scores rather than failing silently. GlaKG's central contribution is therefore a clinically auditable reasoning framework that complements raw predictive performance by explicitly exposing the biomarker evidence and rule activations behind each decision.

cs.CV↗

arXiv2025

Automated Glaucoma Report Generation via Dual-Attention Semantic Parallel-LSTM and Multimodal Clinical Data Integration

Generative AI for automated glaucoma diagnostic report generation faces two predominant challenges: content redundancy in narrative outputs and inadequate highlighting of pathologically significant features including optic disc cupping, retinal nerve fiber layer defects, and visual field abnormalities. These limitations primarily stem from current multimodal architectures' insufficient capacity to extract discriminative structural-textural patterns from fundus imaging data while maintaining precise semantic alignment with domain-specific terminology in comprehensive clinical reports. To overcome these constraints, we present the Dual-Attention Semantic Parallel-LSTM Network (DA-SPL), an advanced multimodal generation framework that synergistically processes both fundus imaging and supplementary visual inputs. DA-SPL employs an Encoder-Decoder structure augmented with the novel joint dual-attention mechanism in the encoder for cross-modal feature refinement, the parallelized LSTM decoder architecture for enhanced temporal-semantic consistency, and the specialized label enhancement module for accurate disease-relevant term generation. Rigorous evaluation on standard glaucoma datasets demonstrates DA-SPL's consistent superiority over state-of-the-art models across quantitative metrics. DA-SPL exhibits exceptional capability in extracting subtle pathological indicators from multimodal inputs while generating diagnostically precise reports that exhibit strong concordance with clinical expert annotations.

cs.CE↗

arXiv2025

GlaBoost: A Multimodal Structured Framework for Glaucoma Risk Stratification

Early and accurate glaucoma detection is critical to prevent irreversible vision loss, yet existing AI methods often rely on unimodal inputs and lack interpretability. We present GlaBoost, a multimodal gradient boosting framework that unifies three complementary signals for glaucoma risk prediction: fundus image embeddings from a pretrained convolutional encoder,free-text neuroretinal rim assessments encoded by a transformer-based language model, and structured ophthalmic biomarkers. These modalities are fused into a single representation and classified by an enhanced XGBoost model.On two real-world annotated datasets, GlaBoost consistently outperforms unimodal and generic multimodal baselines. Feature importance analysis highlights the cup-to-disc ratio, rim thinning, and the ISNT rule as the dominant predictors, yielding clinically consistent and interpretable decisions. GlaBoost offers a transparent and scalable foundation for multimodal decision support in ophthalmology.

cs.LG↗

arXiv2025

X-GAN: A Generative AI-Powered Unsupervised Model for Main Vessel Segmentation of Glaucoma Screening

Structural changes in main retinal blood vessels serve as critical biomarkers for the onset and progression of glaucoma. Identifying these vessels is vital for vascular modeling yet highly challenging. This paper proposes X-GAN, a generative AI-powered unsupervised segmentation model designed for extracting main blood vessels from Optical Coherence Tomography Angiography (OCTA) images. The process begins with the Space Colonization Algorithm (SCA) to rapidly generate a skeleton of vessels, featuring their radii. By synergistically integrating the generative adversarial network (GAN) with biostatistical modeling of vessel radii, X-GAN enables a fast reconstruction of both 2D and 3D representations of the vessels. Based on this reconstruction, X-GAN achieves nearly 100\% segmentation accuracy without relying on labeled data or high-performance computing resources. Experimental results confirm X-GAN's superiority in evaluating main vessel segmentation compared to existing deep learning models.

eess.IV↗

arXiv2024

GlaLSTM: A Concurrent LSTM Stream Framework for Glaucoma Detection via Biomarker Mining

Glaucoma is a complex group of eye diseases marked by optic nerve damage, commonly linked to elevated intraocular pressure and biomarkers like retinal nerve fiber layer thickness. Understanding how these biomarkers interact is crucial for unraveling glaucoma's underlying mechanisms. In this paper, we propose GlaLSTM, a novel concurrent LSTM stream framework for glaucoma detection, leveraging latent biomarker relationships. Unlike traditional CNN-based models that primarily detect glaucoma from images, GlaLSTM provides deeper interpretability, revealing the key contributing factors and enhancing model transparency. This approach not only improves detection accuracy but also empowers clinicians with actionable insights, facilitating more informed decision-making. Experimental evaluations confirm that GlaLSTM surpasses existing state-of-the-art methods, demonstrating its potential for both advanced biomarker analysis and reliable glaucoma detection.

eess.IV↗